Dr. Peter Green [CDF Medical Advisory Board] Co-Authors Study on Mucosal Healing / Fracture Risk in Celiac Disease
Study Title: Mucosal Healing and Risk of Fracture in Celiac Disease (Outcomes: epidemiology)
Presented at Digestive Disease Week - May 19, 2013
Drs. Joseph Murray and Peter Green [CDF Medical Avisory Board] are Among Esteemed Authors of LPM in Celiac Disease Study
Study Title: Mucosal Healing and Risk of Lymphoproliferative Malignancy in Celiac Disease (Outcomes: epidemiology)
Presented at Digestive Disease Week - May 19, 2013
CDF Medical Advisory Board Member Alessio Fasano Co-Authors Study on Stem Cell Pathways in Acute Celiac Disease
Study Title: Expression Analysis of Intestinal Stem Cell Signaling Pathways in Acute Celiac Disease (Stem Cells)
Presented at Digestive Disease Week - May 19, 2013
American College of Gastroenterology Publishes Clinical Guidelines on the Diagnosis and Managment of Celiac Disease.
The list of contributing authors reads like a celiac disease hall-of-fame: Alberto Rubio-Tapia, MD, Ivor D. Hill, MD, Ciarán P. Kelly, MD, Audrey H. Calderwood, MD and Joseph A. Murray, MD.
The guidelines provide 21 pages of much needed information for physicians who tend to perceive CD as a rare disease and often fail to consider it even with typical presentations.
April 2013
Recognizing Celiac Disease in Kids
Ritu Verma, MD Pediatric gastroenterologist and Director of the Center for Celiac Disease at Children's Hospital in Philadelphia.
Click Here to Read MoreCan an Increase in Celiac Disease Be Attributed to an Increase in the 2 Gluten Content of Wheat as a Consequence of Wheat Breeding?
This article was written in response to the suggestion that an increase in the incidence of celiac disease might be attributable to an increase in the gluten content of wheat resulting from wheat breeding.
Click Here to Read MoreGluten-Free, Whether You Need It or Not
Now medical experts largely agree that there is a condition related to gluten other than celiac. In 2011 a panel of celiac experts convened in Oslo and settled on a medical term for this malady: non-celiac gluten sensitivity.
Click Here to Read MoreMucosal Healing and Mortality in Coeliac Disease
A new study from Sweden looks at villous atrophy and mortality in coeliac disease.
Click Here to Read MoreSerum parameters in the spectrum of coeliac disease: beyond standard antibody testing - a cohort study
Invasive techniques are still required to distinguish between uncomplicated and complicated forms of CD.
Click Here to Read MoreAntibody Repertoire Profiling Using Bacterial Display Identifies Reactivity Signatures of Celiac Disease
A general strategy to identify serum antibody specificities associated with a given disease state and peptide reagents for their detection was developed using bacterial display peptide libraries and multiparameter flow cytometry.
Click Here to Read MoreVictory for Celiacs at Lesley University, Cambridge, Massachusetts
In compliance with the Americans with Disabilities Act, which prohibits discrimination against individuals with disabilities by public accommodations, the Justice Department announced an agreement on Thursday, December 20th with Lesley University in Cambridge, Massachusetts.
Click Here to Read MoreRELATED STORIES
College Students With Food Allergies Make Legal Gains from NPR
includes interview with Marilyn G. Geller, Chief Operating Officer of Celiac Disease Foundation
Food (Allergy) Fight: Safe Student Dining a Right from University Business
Prevalence of Migraine in Patients With Celiac Disease and Inflammatory Bowel Disease
Objective: To assess the prevalence of headache in clinic and support group patients with celiac disease and inflammatory bowel disease (IBD) compared with a sample of healthy controls.
Click Here to Read MoreDiagnosing Celiac Disease by Video Capsule Endoscopy (VCE) When Esophogastroduodenoscopy (EGD) and Biopsy is Unable to Provide a Diagnosis
Video capsule endoscopy (VCE) is mainly used to evaluate patients with celiac disease in whom their course after diagnosis has been unfavorable and the diagnosis of adenocarcinoma, lymphoma or refractory celiac disease is entertained, but it has been suggested that VCE could replace esophagogastroduodenoscopy (EGD) and biopsy under certain circumstances.
Click Here to Read MoreMulticenter Study on Season of Birth and Celiac Disease: Evidence for a New Theoretical Model of Pathogenesis
Objective: To investigate whether season of birth is associated with celiac disease (CD).
Click Here to Read MoreMass Screening for Celiac Disease From the Perspective of Newly Diagnosed Adolescents and Their Parents
Mass screening for celiac disease (CD) as a public health intervention is controversial. Prior to implementation, acceptability to the targeted population should be addressed.
Click Here to Read MoreIn Vitro Gliadin Challenge: Diagnostic Accuracy and Utility for the Difficult Diagnosis of Celiac Disease
Diagnosis of celiac disease is difficult when treatment with gluten-free diet (GFD) is started before diagnosis and/or when the results of tests are inconsistent. The objective of this study was to evaluate the in vitro gliadin challenge.
Click Here to Read MoreReduced risk of breast, endometrial and ovarian cancer in women with celiac disease
Women with celiac disease (CD) may be at decreased risk of female hormone-related cancers given the observed reduction in breast cancer seen in some cohorts.
Click Here to Read MoreIncidence of Lymphoproliferative Disorders in Patients with Celiac Disease
Prior studies describe an increased incidence of lymphoma in celiac disease. However, few studies differentiate among lymphoproliferative disorders (LPDs).
Click Here to Read MoreThe Incidence and Risk of Celiac Disease in a Healthy US Adult Population
Several factors are hypothesized as possible disease triggers including intercurrent illnesses, such as gastroenteritis, surgeries, and trauma.
Click Here to Read MoreLongstanding Celiac Disease a Risk Factor for Diabetic Retinopathy
Longstanding celiac disease is associated with an increased risk of diabetic retinopathy in patients with type 1 diabetes, a new study finds.
Click Here to Read MoreBrain Abnormalities Common in Celiac Disease Patients
Patients with celiac disease and neurologic symptoms have substantial structural and functional brain deficits as detected on magnetic resonance imaging (MRI), British investigators have observed.
Click Here to Read MoreBioLineRx Announces Pre-clinical Results Demonstrating the Safety of BL-7010
BioLineRx, a biopharmaceutical development company, announced today that BL-7010, an orally available treatment for celiac disease, was found to be safe and well tolerated in pre-clinical studies conducted to date.
Click Here to Read MoreImmusanT Initiates Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac Disease
ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2®, the first therapeutic vaccine for patients with celiac disease.
Click Here to Read MoreNon-Celiac Wheat Sensitivity Diagnosed by Double-Blind Placebo-Controlled Challenge
Non-celiac wheat sensitivity (WS) is considered a new clinical entity. An increasing percentage of the general population avoids gluten ingestion.
Click Here to Read MoreCanadian Celiac Association Celebrates New Gluten Labeling Laws
Three million Canadians with celiac disease and gluten sensitivity will be safer now that new federal legislation on food labeling has gone into effect.
Click Here to Read MoreOne of every 100 U.S. whites has celiac disease
One percent of non-Hispanic whites in the U.S. - close to two million Americans - have celiac disease, but most are not aware they suffer the gluten-intolerance problem, according to a new study.
Click Here to Read MoreAdults with celiac disease needed for a research study!
Alvine Pharmaceuticals is looking for people with celiac disease to test the new survey while eating a food with or without a small amount of gluten.
Click Here to Read MoreALV003 Receives Fast Track Designation From the FDA
Alvine Pharmaceuticals announced today that its lead candidate, ALV003, received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the potential treatment of patients with celiac disease. Alvine is currently conducting phase 2 clinical trials with ALV003.
Click Here to Read MoreFDA Safety and Innovation Act
Statement from HHS Secretary Kathleen Sebelius on the signing of the Food and Drug Administration Safety and Innovation Act
Click Here to Read MoreThe Rewards and Risks of a Gluten-Free Diet
Gluten-free. It's the new buzz word as far as celebrity diets are concerned.
Click Here to Read MoreEarly Vaccinations Are Not Risk Factors for Celiac Disease
Despite unfounded fears about the side effects of vaccines, the early vaccination of children is not linked to a recent increase in the number of celiac disease diagnoses, says a new study published in the July 2012 issue of the journal Pediatrics.
Click Here to Read MoreGluten-free is not always the way to be
Kim Kardashian and Miley Cyrus are two of the latest celebrities to tout the gluten-free diet as the way to go when it comes to leading a healthy lifestyle, following in the footsteps of the likes of Victoria Beckham, Elisabeth Hasselbeck and Gwyneth Paltrow.
Click Here to Read MoreAlba Therapeutics Recruiting for a Phase 2b Clinical Trial
Alba Therapeutics Corporation today announced that it was granted a certificate of registration for copyright of the first and only Patient Reported Outcome (PRO) questionnaire for patients with Celiac Disease (CeD).
Click Here to Read MoreFDA Moves Forward on Gluten-free Labeling Rules
Los Angeles, CA – August 2, 2011 – The Food and Drug Administration announced today that it is reopening the public comment period on the gluten-free labeling proposal it issued in 2007, mandated by a seven-year-old allergen labeling law.
Click Here to Read MoreUniversity of Maryland School of Medicine Researchers Identify Key Pathogenic Differences Between Celiac Disease and Gluten Sensitivity
Study from University of Maryland Center for Celiac Research Places Gluten Sensitivity on Center Stage of Spectrum of Gluten-Related Disorders
Baltimore, MD – March 10, 2011. Scientists at the University of Maryland School of Medicine’s Center for Celiac Research have proven that gluten sensitivity is different from celiac disease at the molecular level and in the response it elicits from the immune system. The research, published online in BMC Medicine, provides the first scientific evidence of a different mechanism leading to gluten sensitivity. It also demonstrates that gluten sensitivity and celiac disease are part of a spectrum of gluten-related disorders.
Click Here to Read MoreMouse Study Suggests New Clues to Celiac Disease
Retinoic acid might spur digestive disorder in those with genetic susceptibility
By Madonna Behen
HealthDay Reporter
A key discovery into how celiac disease develops may pave the way toward preventing this painful digestive disorder in those most at risk, a new animal study suggests. Using mice, scientists at the University of Chicago have identified a biochemical interaction...
Click Here to Read MoreUC San Diego
"Celiac Disease and Gluten: Facts, Fiction & Controversies"
UC San Diego Warren Celiac Center's Community Lecture
With Martin Kagnoff, MD, Kimberly Newton, MD and Shawna McNally, RD











